Biosino Bio-Technology and Science Incorporation (HKG:8247)

HKG:8247 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	18.26	43.52	68.21	63.41	77.35	44.47
Short-Term Investments	-	0.86	6.75	8.68	6.96	6.27
Trading Asset Securities	2	-	-	-	-	-
Cash & Short-Term Investments	20.26	44.38	74.96	72.09	84.31	50.74
Cash Growth	-56.29%	-40.80%	3.98%	-14.49%	66.17%	-7.82%
Accounts Receivable	98.68	106.68	121.54	179.8	215.51	207.44
Other Receivables	30.78	-	-	-	-	-
Receivables	129.47	137.78	152.7	212.45	246.67	241.87
Inventory	40.05	43.61	53.76	60.41	55.49	60
Other Current Assets	0.35	4.24	3.98	5.18	11	55.47
Total Current Assets	197.2	230	285.41	350.14	397.46	408.08
Property, Plant & Equipment	49.04	61.49	74.55	83.68	85.17	106.84
Long-Term Investments	80.72	74.44	74.66	78.45	66.1	60.81
Other Intangible Assets	15.05	13.79	18.69	20.45	23.36	22.3
Long-Term Accounts Receivable	-	0.5	0.5	0.5	2.7	0.77
Long-Term Deferred Tax Assets	9.36	9.36	5.37	3.23	3.93	3.49
Long-Term Deferred Charges	4.15	-	-	6.09	3.08	4.88
Other Long-Term Assets	17.87	17.55	18.2	20.71	21.44	0.6
Total Assets	373.39	407.12	477.37	563.25	603.24	607.76

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	59.84	62.67	87.11	111.54	137.01	145.67
Accrued Expenses	16.84	16.71	21.12	28.55	31.2	25.72
Short-Term Debt	104.42	97.87	91.86	107.75	102.55	152.57
Current Portion of Long-Term Debt	-	54.03	51.8	32.99	31	9.18
Current Portion of Leases	-	0.49	3.36	5.24	3.29	2.51
Current Income Taxes Payable	-	0	0.01	0.22	3.47	3.47
Current Unearned Revenue	11.22	10.01	6.74	12.24	11.63	16.75
Other Current Liabilities	68.83	38.63	30.89	22.23	26.11	33.17
Total Current Liabilities	261.14	280.41	292.9	320.75	346.26	389.03
Long-Term Debt	7.93	8.57	4.56	1.98	7.55	0.03
Long-Term Leases	1.59	1.95	2.27	3.49	7.3	9.24
Long-Term Unearned Revenue	-	-	-	0.07	0.83	2.46
Long-Term Deferred Tax Liabilities	3.18	3.24	3.19	5.56	7.2	7.59
Total Liabilities	273.84	294.17	302.91	331.85	369.14	408.35

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	144.71	144.71	144.71	144.71	144.71	144.71
Retained Earnings	45.52	-167.7	-116.55	-74.02	-62.37	-70.48
Comprehensive Income & Other	-239.68	143.17	139.65	139.7	123.52	101.95
Total Common Equity	111.8	120.18	167.81	210.39	205.85	176.17
Minority Interest	-12.26	-7.23	6.66	21.02	28.26	23.24
Shareholders' Equity	99.55	112.96	174.47	231.4	234.11	199.41
Total Liabilities & Equity	373.39	407.12	477.37	563.25	603.24	607.76

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	113.94	162.91	153.85	151.45	151.69	173.53
Net Cash (Debt)	-93.68	-118.54	-78.89	-79.36	-67.38	-122.8
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.67	-0.82	-0.55	-0.55	-0.47	-0.85
Filing Date Shares Outstanding	138.85	144.71	144.71	144.71	144.71	144.71
Total Common Shares Outstanding	138.85	144.71	144.71	144.71	144.71	144.71
Working Capital	-63.94	-50.4	-7.49	29.39	51.2	19.05
Book Value Per Share	0.81	0.83	1.16	1.45	1.42	1.22
Tangible Book Value	96.75	106.4	149.12	189.94	182.49	153.88
Tangible Book Value Per Share	0.70	0.74	1.03	1.31	1.26	1.06
Buildings	-	-	-	40.9	40.9	62.93
Machinery	-	-	-	222.26	225.77	211.41
Leasehold Improvements	-	-	-	49.68	43.39	39.16

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 22, 2026

Data Sources Report a data error